1st Quarter - Report

ZERO PROSTATE CANCER for ZERO PROSTATE CANCER

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

prostate cancer research program defense appropriations

LobbyistCovered position, as disclosed
MATTHEW MARKS —
ANDREW SAELENS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Insurance INS

Working on a bill to get men at high risk for prostate cancer access who are commercially insured to a PSA with no copay

LobbyistCovered position, as disclosed
MATTHEW MARKS —
ANDREW SAELENS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Prostate Cancer Research Program at the Department of Defense Appropriations for Centers for Disease Control funding

LobbyistCovered position, as disclosed
MATTHEW MARKS —
ANDREW SAELENS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.